Abstract
AbstractFrailty is a multifaceted clinical state associated with accelerated aging and adverse health outcomes. Informed etiological models of frailty hold promise for producing widespread health improvements across the aging population. Frailty is currently measured using aggregate scores, which obscure etiological pathways that are only relevant to subcomponents of frailty. Therefore, we performed the first multivariate genome-wide association study of the latent genetic architecture between 30 frailty deficits, which identified 408 genomic risk loci. Our model included a general factor of genetic overlap across all deficits, plus six novel factors indexing shared genetic signal across specific groups of deficits. Follow-up analyses demonstrated the added clinical and etiological value of the six factors, including predicting frailty in external datasets, divergent genetic correlations with clinically relevant outcomes, and unique underlying biology linked to aging. This suggests nuanced models of frailty are key to understanding its causes and how it relates to worse health.
Publisher
Cold Spring Harbor Laboratory
Reference154 articles.
1. The dynamics of frailty development and progression in older adults in primary care in England (2006–2017): a retrospective cohort profile;BMC Geriatrics,2022
2. Frailty index as a predictor of mortality: a systematic review and meta-analysis;Age and Ageing,2017
3. Frailty and hospitalization-associated disability after pneumonia: A prospective cohort study;BMC Geriatrics,2021
4. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies;Age and Ageing,2020
5. The Identification of Hereditary and Environmental Determinants of Frailty in a Cohort of UK Twins;Twin Research and Human Genetics,2016